Novozymes As Stock Technical Analysis
| NVZMY Stock | USD 64.28 0.65 1.00% |
As of the 28th of January, Novozymes secures the Downside Deviation of 1.35, mean deviation of 1.12, and Risk Adjusted Performance of 0.0201. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novozymes AS, as well as the relationship between them.
Novozymes Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Novozymes, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NovozymesNovozymes |
Novozymes 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novozymes' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novozymes.
| 10/30/2025 |
| 01/28/2026 |
If you would invest 0.00 in Novozymes on October 30, 2025 and sell it all today you would earn a total of 0.00 from holding Novozymes AS or generate 0.0% return on investment in Novozymes over 90 days. Novozymes is related to or competes with Sika AG, Sika AG, PT Chandra, ArcelorMittal, Givaudan, Givaudan, and Akzo Nobel. Novozymes AS produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, N... More
Novozymes Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novozymes' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novozymes AS upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.35 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 9.94 | |||
| Value At Risk | (2.15) | |||
| Potential Upside | 3.11 |
Novozymes Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novozymes' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novozymes' standard deviation. In reality, there are many statistical measures that can use Novozymes historical prices to predict the future Novozymes' volatility.| Risk Adjusted Performance | 0.0201 | |||
| Jensen Alpha | (0.0002) | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0685 |
Novozymes January 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0201 | |||
| Market Risk Adjusted Performance | 0.0785 | |||
| Mean Deviation | 1.12 | |||
| Semi Deviation | 1.28 | |||
| Downside Deviation | 1.35 | |||
| Coefficient Of Variation | 5057.71 | |||
| Standard Deviation | 1.65 | |||
| Variance | 2.73 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.0002) | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0685 | |||
| Maximum Drawdown | 9.94 | |||
| Value At Risk | (2.15) | |||
| Potential Upside | 3.11 | |||
| Downside Variance | 1.83 | |||
| Semi Variance | 1.64 | |||
| Expected Short fall | (1.23) | |||
| Skewness | 1.63 | |||
| Kurtosis | 6.02 |
Novozymes AS Backtested Returns
At this stage we consider Novozymes Pink Sheet to be very steady. Novozymes AS has Sharpe Ratio of 0.0718, which conveys that the firm had a 0.0718 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Novozymes, which you can use to evaluate the volatility of the firm. Please verify Novozymes' Downside Deviation of 1.35, risk adjusted performance of 0.0201, and Mean Deviation of 1.12 to check out if the risk estimate we provide is consistent with the expected return of 0.12%. Novozymes has a performance score of 5 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.33, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Novozymes' returns are expected to increase less than the market. However, during the bear market, the loss of holding Novozymes is expected to be smaller as well. Novozymes AS right now secures a risk of 1.64%. Please verify Novozymes AS kurtosis, market facilitation index, and the relationship between the semi variance and rate of daily change , to decide if Novozymes AS will be following its current price movements.
Auto-correlation | 0.26 |
Poor predictability
Novozymes AS has poor predictability. Overlapping area represents the amount of predictability between Novozymes time series from 30th of October 2025 to 14th of December 2025 and 14th of December 2025 to 28th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novozymes AS price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current Novozymes price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 1.32 |
Novozymes technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Novozymes AS Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Novozymes AS across different markets.
About Novozymes Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Novozymes AS on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Novozymes AS based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Novozymes AS price pattern first instead of the macroeconomic environment surrounding Novozymes AS. By analyzing Novozymes's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Novozymes's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Novozymes specific price patterns or momentum indicators. Please read more on our technical analysis page.
Novozymes January 28, 2026 Technical Indicators
Most technical analysis of Novozymes help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Novozymes from various momentum indicators to cycle indicators. When you analyze Novozymes charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0201 | |||
| Market Risk Adjusted Performance | 0.0785 | |||
| Mean Deviation | 1.12 | |||
| Semi Deviation | 1.28 | |||
| Downside Deviation | 1.35 | |||
| Coefficient Of Variation | 5057.71 | |||
| Standard Deviation | 1.65 | |||
| Variance | 2.73 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.0002) | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0685 | |||
| Maximum Drawdown | 9.94 | |||
| Value At Risk | (2.15) | |||
| Potential Upside | 3.11 | |||
| Downside Variance | 1.83 | |||
| Semi Variance | 1.64 | |||
| Expected Short fall | (1.23) | |||
| Skewness | 1.63 | |||
| Kurtosis | 6.02 |
Novozymes January 28, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Novozymes stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 48.41 | ||
| Daily Balance Of Power | (0.84) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 64.43 | ||
| Day Typical Price | 64.38 | ||
| Price Action Indicator | (0.47) | ||
| Market Facilitation Index | 0.0002 |
Additional Tools for Novozymes Pink Sheet Analysis
When running Novozymes' price analysis, check to measure Novozymes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novozymes is operating at the current time. Most of Novozymes' value examination focuses on studying past and present price action to predict the probability of Novozymes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novozymes' price. Additionally, you may evaluate how the addition of Novozymes to your portfolios can decrease your overall portfolio volatility.